BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23645587)

  • 1. Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model.
    Cavanagh JP; Granslo HN; Fredheim EA; Christophersen L; Jensen PØ; Thomsen K; Van Gennip M; Klingenberg C; Flaegstad T; Moser C
    J Antimicrob Chemother; 2013 Sep; 68(9):2106-10. PubMed ID: 23645587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm.
    Aybar Y; Ozaras R; Besirli K; Engin E; Karabulut E; Salihoglu T; Mete B; Tabak F; Mert A; Tahan G; Yilmaz MH; Ozturk R
    Int J Antimicrob Agents; 2012 Apr; 39(4):338-42. PubMed ID: 22364717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model.
    Christensen LD; van Gennip M; Jakobsen TH; Alhede M; Hougen HP; Høiby N; Bjarnsholt T; Givskov M
    J Antimicrob Chemother; 2012 May; 67(5):1198-206. PubMed ID: 22302561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
    Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA
    Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should cefazolin or vancomycin be used for initial empiric coverage for Staphylococcus aureus in peritoneal dialysis associated peritonitis?
    Hansson JH
    Semin Dial; 2011; 24(4):449-50. PubMed ID: 21851410
    [No Abstract]   [Full Text] [Related]  

  • 6. Daptomycin in peritoneal dialysis, intraperitoneal or intravenous.
    Pérez Melón C; Borrajo Prol M; Iglesias E; Ferreiro B; Camba Caride M
    Nefrologia; 2016; 36(4):461-2. PubMed ID: 26680497
    [No Abstract]   [Full Text] [Related]  

  • 7. Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients.
    Klimek K; Aresté Fosalba N; Ramírez López MÁ; Gómez Castilla AC; Salgueira Lazo M
    Nefrologia (Engl Ed); 2020; 40(2):197-201. PubMed ID: 31208832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment.
    Broekhuizen CA; de Boer L; Schipper K; Jones CD; Quadir S; Vandenbroucke-Grauls CM; Zaat SA
    J Biomed Mater Res A; 2008 May; 85(2):498-505. PubMed ID: 17729261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peritonitis due to glycopeptides-resistant Staphylococcus epidermidis].
    Watine J; Ciobotaru M; Lombart D; Thomas K; Amirou M
    Ann Biol Clin (Paris); 2010; 68(1):99-103. PubMed ID: 20146979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections.
    Chilukuri DM; Shah JC
    Pharm Res; 2005 Apr; 22(4):563-72. PubMed ID: 15846464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal urokinase and oral rifampicin for persisting asymptomatic dialysate infection following acute coagulase-negative staphylococcus peritonitis.
    Demoulin N; Goffin E
    Perit Dial Int; 2009; 29(5):548-53. PubMed ID: 19776049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of peritonitis in patients on chronic peritoneal dialysis with a single dose of vancomycin].
    Radovanović Lj
    Srp Arh Celok Lek; 1996; 124 Suppl 1():151-3. PubMed ID: 9102885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
    Domínguez-Herrera J; López-Rojas R; Smani Y; Labrador-Herrera G; Pachón J
    Int J Antimicrob Agents; 2016 Dec; 48(6):661-665. PubMed ID: 28128094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with intravenous daptomycin for a peritonitis relapse caused by Staphylococcus epidermidis.
    Levy F; Camarero Temiño V; Blasco Mollá A; Ortega Lafont MP; Abaigar Luquin P; Izquierdo Ortiz MJ; Torres Torres G
    Nefrologia; 2011; 31(3):374-5. PubMed ID: 21629350
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
    Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin.
    Sieradzki K; Roberts RB; Serur D; Hargrave J; Tomasz A
    Lancet; 1998 Mar; 351(9106):880-1. PubMed ID: 9525371
    [No Abstract]   [Full Text] [Related]  

  • 17. Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model.
    Nodzo SR; Tobias M; Ahn R; Hansen L; Luke-Marshall NR; Howard C; Wild L; Campagnari AA; Ehrensberger MT
    Clin Orthop Relat Res; 2016 Jul; 474(7):1668-75. PubMed ID: 26801677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo.
    Zhang Y; Fu Y; Yu J; Ai Q; Li J; Peng N; Song S; He Y; Wang Z
    J Infect Chemother; 2015 Nov; 21(11):808-15. PubMed ID: 26423688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.
    Sieradzki K; Roberts RB; Serur D; Hargrave J; Tomasz A
    J Clin Microbiol; 1999 Jan; 37(1):39-44. PubMed ID: 9854061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus epidermidis with intermediate resistance to vancomycin: elusive phenotype or laboratory artifact?
    Dunne WM; Qureshi H; Pervez H; Nafziger DA
    Clin Infect Dis; 2001 Jul; 33(1):135-7. PubMed ID: 11389509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.